Trial intelligence / Profile preview

Avastin injection for treatment of pterygium

IRCT2014092819319N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jul 2013
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Countries
1
01

Overview

Phase 3 trial of bevacizumab in pterygium, sponsored by Iran University of Medical Sciences. Started Jul 2013; status: completed.

02

Drugs

bevacizumab
03

Conditions

pterygium

Beyond the preview

Go deeper on IRCT2014092819319N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014092819319N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call